Records containing: Unresectable Pancreatic Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 1 Study of Gemcitabine, Nab-Paclitaxel, and Bosentan in Patients With Unresectable Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 1 Study of Olaparib in Combination With Durvalumab (MEDI4736) and Concurrent Radiation Therapy Following First-Line Chemotherapy in Locally Advanced Unresectable Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2026-04-13Phase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-04-13Phase I Clinical Trial of M6620 (VX-970, Berzosertib) in Combination With the Topoisomerase I Inhibitor Irinotecan in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2026-02-04A Pilot Study of Gemcitabine, Abraxane, Metformin and a Standardized Dietary Supplement (DS) in Patients With Unresectable Pancreatic Cancer
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-09Phase IB Trial of Niraparib and Dostarlimab (TSR-042) in Patients With BRCA-Mutated Breast, Pancreas or Ovary Cancer
-
CLINICAL_TRIALS study record update · 2025-12-12A Phase 1 / 2 Multiple-indication Biomarker, Safety, and Efficacy Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab
-
CLINICAL_TRIALS study record update · 2025-12-05A Phase Ib Study of Guadecitabine (SGI-110) and Durvalumab (MEDI 4736) in Patients With Advanced Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, and Cholangiocarcinoma/Gallbladder Cancer
-
CLINICAL_TRIALS study record update · 2025-10-09Effects on QOL When Zinc is Supplemented in Patients With Upper GI Cancer on Chemotherapy
-
CLINICAL_TRIALS study record update · 2025-07-30Phase II Study of EUS-Guided Verteporfin PDT in Solid Pancreatic Tumors (VERTPAC-02)
-
CLINICAL_TRIALS study record update · 2025-04-16THREAD: A Phase I Trial of Trametinib and Hydroxychloroquine in Patients With Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2025-01-07A Phase I/II Study of Trifluridine/Tipiracil (TAS102) in Combination With Nanoliposomal Irinotecan (NAL-IRI) in Advanced GI Cancers
-
CLINICAL_TRIALS study record update · 2024-07-30A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2023-12-05Phase Ib Trial of Pembrolizumab and XL888 in Patients With Advanced Gastrointestinal Malignancies
-
CLINICAL_TRIALS study record update · 2023-09-22A Multinational, Randomized, Phase II Study of the Combination of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab, an IL-6R Inhibitor, as First-line Treatment in Patients With Locally Advanced or Metastatic Pancreatic Cancer.
-
CLINICAL_TRIALS study record update · 2023-04-25A Phase I and Randomized Phase II Study of Nab-Paclitaxel/Gemcitabine With or Without AZD1775 for Treatment of Metastatic Adenocarcinoma of the Pancreas
-
CLINICAL_TRIALS study record update · 2020-09-28Phase I Study of GSK525762C and Entinostat in Advanced and Refractory Solid Tumors and Lymphomas
-
CLINICAL_TRIALS study record update · 2020-01-18A Pilot Study of Intravenous Ascorbic Acid and Folfirinox in the Treatment of Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2017-08-22A Phase I Trial of Dinaciclib (SCH727965) and MK-2206 in Metastatic Pancreatic Cancer With an Expansion Cohort in Advanced Pancreatic Cancer